评估心理教育干预对64岁以上初级保健人群中苯二氮卓的使用的有效性 (BENZOS-AP)
这项务实的,多中心,随机对照临床试验的目的是确定有关苯二氮卓类使用的教育干预是否可以减少64岁以上患者的这些药物的消费和/或剂量。
它旨在提供知识和技能,以帮助参与者容忍或减少不适,从而使他们能够开始减少或停止使用苯二氮卓(BZD)。
重点是合并护理的效果,但还评估了这种方法的实施,为基层医疗保健的进一步发展提供了宝贵的见解。
研究人员将比较最少的干预措施,包括向每个参与者的邮寄地址发送“苯甲刀”,并进行密集的干预措施,此外还包括心理教育会议和治疗性练习。
干预小组的参与者将在初级保健中心参加八周的课程。
研究概览
地位
干预/治疗
详细说明
Long-term benzodiazepine use is common among older adults despite recommendations limiting treatment duration because of the increased risk of dependence, falls, cognitive impairment and other adverse effects. Although several interventions have been proposed to support benzodiazepine deprescribing, their implementation in routine primary care remains limited.
This pragmatic, multicenter randomized controlled trial was designed to evaluate the effectiveness of a multidisciplinary intervention delivered in routine primary care. The intervention combined a minimal educational strategy consisting of a personalized letter from the participant's family physician ("Benzocarta") with an 8-week group-based psychoeducational program and supervised therapeutic exercise. The comparator group received the minimal educational intervention alone, reflecting usual clinical practice.
The intervention was delivered by a multidisciplinary primary care team and focused on promoting benzodiazepine deprescribing through education, behavioural strategies and non-pharmacological management of insomnia, anxiety and stress.
The study was conducted under real-world conditions in four primary care centres. Although the minimum required sample size was 69 participants, recruitment continued during the planned recruitment period because additional family physicians agreed to participate during the planned recruitment period. Consequently, the final enrolled sample exceeded the minimum target specified in the original protocol (122 participants).
Follow-up assessments were performed at 6 and 18 months after the initial intervention to evaluate the long-term sustainability of benzodiazepine deprescribing and the occurrence of late relapse in benzodiazepine use.
Protocol amendment: An additional follow-up assessment at 18 months after the initial intervention was incorporated before data analysis to evaluate the persistence of benzodiazepine discontinuation and potential late relapse. This amendment did not modify participant allocation, study interventions, or outcome definitions.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Lleida
-
Almenar、Lleida、西班牙、25126
- Primary Care Team of Alfarràs-Almenar.
-
-
参与标准
资格标准
适合学习的年龄
- 年长者
接受健康志愿者
描述
纳入标准:
- 64岁以上的人已经使用苯二氮卓类药物了三个月或更长时间。
- 有积极诊断焦虑和/或失眠的人。
排除标准:
- 具有精神病合并症,痴呆症,癫痫病的人,包括家庭护理计划(ATDON),制度化或姑息治疗中。
- 没有接触或语言障碍的人。
- 难以前往初级保健中心(CAP)的人。
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
假比较器:控制
通过邮政邮寄一封信
|
向每个人的邮政地址发送一个“苯甲卡塔尔”,由他们的家庭医生签名的个性化信,一张有关如何逐渐减少药物的解释性表,以及有关睡眠卫生,压力或焦虑的信息图表。
|
|
有源比较器:实验
通过邮政邮寄一封信以及心理教育干预和治疗活动。
|
目的是提供知识和技能,以耐受/减少不适,以便他们可以开始减少或停止药物(BZD)。 重点是合并护理的效果,但还评估了这种方法的实施,这将为基层医疗保健的进一步发展提供宝贵的知识。 |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of participants who completely discontinued benzodiazepine treatment
大体时间:6 and 18 months after the initial intervention
|
Complete discontinuation of prescribed benzodiazepine treatment, defined as the absence of benzodiazepine use at follow-up, regardless of the baseline dose.
The outcome was assessed by comparing the proportion of participants who had completely discontinued treatment in the intervention and control groups.
|
6 and 18 months after the initial intervention
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in weekly benzodiazepine dose expressed as diazepam equivalents
大体时间:6 and 18 months after the initial intervention
|
Change from baseline in the prescribed weekly benzodiazepine dose, expressed as diazepam-equivalent milligrams per week, comparing the intervention and control groups.
Among participants who did not completely discontinue treatment, the proportions achieving partial dose reduction or maintaining the same dose were also described.
|
6 and 18 months after the initial intervention
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.